Work Now To Build The Alzheimer's Commercial Landscape, McClellan Advises
Executive Summary
Duke Margolis Center for Health Policy director Mark McClellan recommended CMS and drug manufacturers coordinate to build a clearer commercial path for Alzheimer's treatments.